Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 725

1.

[Polyneuropathy in the elderly].

Löscher W, Iglseder B.

Z Gerontol Geriatr. 2017 Apr 28. doi: 10.1007/s00391-017-1233-3. [Epub ahead of print] German.

PMID:
28455594
2.

Response to comment on "Peripheral nerve function in patients with excessive fragmentary myoclonus during sleep".

Raccagni C, Löscher WN, Stefani A, Wanschitz J, Heidbreder A, Högl B.

Sleep Med. 2017 May;33:194. doi: 10.1016/j.sleep.2016.11.006. Epub 2016 Nov 30. No abstract available.

PMID:
28381346
3.

Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.

Finsterer J, Wanschitz J, Quasthoff S, Iglseder S, Löscher W, Grisold W.

Acta Neurol Scand. 2017 Mar 12. doi: 10.1111/ane.12758. [Epub ahead of print] Review.

PMID:
28295152
4.

Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Löscher W.

Neurochem Res. 2017 Mar 13. doi: 10.1007/s11064-017-2222-z. [Epub ahead of print]

PMID:
28290134
5.

Early-onset Hirayama disease in a female.

Baumann M, Finsterer J, Gizewski ER, Löscher WN.

SAGE Open Med Case Rep. 2017 Jan 1;5:2050313X16686710. doi: 10.1177/2050313X16686710. eCollection 2017.

6.

Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.

Römermann K, Fedrowitz M, Hampel P, Kaczmarek E, Töllner K, Erker T, Sweet DH, Löscher W.

Neuropharmacology. 2017 May 1;117:182-194. doi: 10.1016/j.neuropharm.2017.02.006. Epub 2017 Feb 10.

PMID:
28192112
7.
8.

Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.

Neßler J, Rundfeldt C, Löscher W, Kostic D, Keefe T, Tipold A.

BMC Vet Res. 2017 Jan 25;13(1):33. doi: 10.1186/s12917-017-0957-z.

9.

Preoperative sport improves the outcome of lumbar disc surgery: a prospective monocentric cohort study.

Tschugg A, Lener S, Hartmann S, Wildauer M, Löscher WN, Neururer S, Thomé C.

Neurosurg Rev. 2017 Jan 13. doi: 10.1007/s10143-017-0811-6. [Epub ahead of print]

PMID:
28091825
10.

Common data elements and data management: Remedy to cure underpowered preclinical studies.

Lapinlampi N, Melin E, Aronica E, Bankstahl JP, Becker A, Bernard C, Gorter JA, Gröhn O, Lipsanen A, Lukasiuk K, Löscher W, Paananen J, Ravizza T, Roncon P, Simonato M, Vezzani A, Kokaia M, Pitkänen A.

Epilepsy Res. 2017 Jan;129:87-90. doi: 10.1016/j.eplepsyres.2016.11.010. Epub 2016 Nov 22.

PMID:
28038337
11.

Viral mouse models of multiple sclerosis and epilepsy: Marked differences in neuropathogenesis following infection with two naturally occurring variants of Theiler's virus BeAn strain.

Bröer S, Hage E, Käufer C, Gerhauser I, Anjum M, Li L, Baumgärtner W, Schulz TF, Löscher W.

Neurobiol Dis. 2017 Mar;99:121-132. doi: 10.1016/j.nbd.2016.12.020. Epub 2016 Dec 22.

PMID:
28017800
12.

Gender differences after lumbar sequestrectomy: a prospective clinical trial using quantitative sensory testing.

Tschugg A, Löscher WN, Lener S, Wildauer M, Hartmann S, Neururer S, Thomé C.

Eur Spine J. 2017 Mar;26(3):857-864. doi: 10.1007/s00586-016-4891-8. Epub 2016 Dec 21.

PMID:
28004244
13.

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?

Steiner N, Schwärzler A, Göbel G, Löscher W, Wanschitz J, Gunsilius E.

Oncotarget. 2017 Jan 17;8(3):5081-5091. doi: 10.18632/oncotarget.13861.

14.

The value of quantitative sensory testing in spine research.

Tschugg A, Löscher WN, Lener S, Hartmann S, Wildauer M, Neururer S, Thomé C.

Neurosurg Rev. 2016 Nov 28. [Epub ahead of print]

PMID:
27896457
15.

Improvement of sensory function after sequestrectomy for lumbar disc herniation: a prospective clinical study using quantitative sensory testing.

Tschugg A, Lener S, Hartmann S, Neururer S, Wildauer M, Thomé C, Löscher WN.

Eur Spine J. 2016 Nov;25(11):3543-3549. Epub 2016 Sep 16.

PMID:
27637902
16.

Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.

Löscher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H.

CNS Drugs. 2016 Nov;30(11):1055-1077. Review.

17.

Isoflurane prevents acquired epilepsy in rat models of temporal lobe epilepsy.

Bar-Klein G, Klee R, Brandt C, Bankstahl M, Bascuñana P, Töllner K, Dalipaj H, Bankstahl JP, Friedman A, Löscher W.

Ann Neurol. 2016 Dec;80(6):896-908. doi: 10.1002/ana.24804.

PMID:
27761920
18.

Secondary myopathy due to systemic diseases.

Finsterer J, Löscher WN, Wanschitz J, Quasthoff S, Grisold W.

Acta Neurol Scand. 2016 Dec;134(6):388-402. doi: 10.1111/ane.12576. Epub 2016 Feb 25. Review.

PMID:
26915593
19.

Memory Effect of the Median Nerve: Can Ultrasound Reliably Depict Carpal Tunnel Release Success?

Steinkohl F, Gruber L, Gruber H, Löscher W, Glodny B, Pülzl P, Baur EM, Loizides A.

Rofo. 2017 Jan;189(1):57-62. doi: 10.1055/s-0042-116241. Epub 2016 Sep 19.

20.

Peripheral nerve function in patients with excessive fragmentary myoclonus during sleep.

Raccagni C, Löscher WN, Stefani A, Wanschitz J, Kraemer L, Heidbreder A, Högl B.

Sleep Med. 2016 Jun;22:61-4. doi: 10.1016/j.sleep.2016.04.018. Epub 2016 Jun 7.

PMID:
27544838

Supplemental Content

Loading ...
Support Center